55
Dravite Therapeutics, Inc. raises $53M under Reg D
Company raise · Closed · Offering $53M · Sold $53M · SAN FRANCISCO, CA · filed 2026-09-03
27
Dravite Therapeutics, Inc. files Form D
Company raise update · Closed · SAN FRANCISCO, CA · Form D/A filed 2026-07-28
$10M+ raise
Why now — by persona
Relevant to: B2B software & services sales. Lead card pending.
People on the filing
| MATTHEW MOORE | Executive Officer, Director |
| JOSEPH SUM | Director |
| BARBARA KOSACZ | Director |
| SANDEEP KULKARNI | Director |
Signed by Matthew Moore, CEO.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.
Other filings by this issuer
52
Dravite Therapeutics, Inc. raises $15M under Reg D
Company raise · Closed · Offering $15M · Sold $15M · SAN FRANCISCO, CA · filed 2026-06-24